Lv51
1128 积分 2025-02-19 加入
In vivo CAR T cell engineering: design principles and open questions
21天前
已完结
The promises and challenges of neoantigen cancer vaccines
21天前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Cancer vaccines and the future of immunotherapy
1个月前
已完结
The promises and challenges of neoantigen cancer vaccines
1个月前
已完结
Clinical development of cancer vaccines
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-Cell Engineering Against Pancreatic Tumors
1个月前
已完结
皖公网安备34019202002308
